These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36523986)

  • 1. Intratumoral microbiome and gastrointestinal cancers.
    Li S; Li Q; Lu W
    Front Oncol; 2022; 12():1047015. PubMed ID: 36523986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microbiome - an integral part of the tumor microenvironment.
    Ciernikova S; Sevcikova A; Stevurkova V; Mego M
    Front Oncol; 2022; 12():1063100. PubMed ID: 36505811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
    Wang M; Yu F; Li P
    Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral microbiota: implications for cancer onset, progression, and therapy.
    Wu J; Zhang P; Mei W; Zeng C
    Front Immunol; 2023; 14():1301506. PubMed ID: 38292482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment.
    Gao F; Yu B; Rao B; Sun Y; Yu J; Wang D; Cui G; Ren Z
    Front Immunol; 2022; 13():1051987. PubMed ID: 36466871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abundance and Metabolism Disruptions of Intratumoral Microbiota by Chemical and Physical Actions Unfreeze Tumor Treatment Resistance.
    Kong F; Fang C; Zhang Y; Duan L; Du D; Xu G; Li X; Li H; Yin Y; Xu H; Zhang K
    Adv Sci (Weinh); 2022 Mar; 9(7):e2105523. PubMed ID: 35037431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of the human microbiome in glioma.
    Liang J; Li T; Zhao J; Wang C; Sun H
    Front Oncol; 2022; 12():781741. PubMed ID: 36003766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness of intratumoral bacteria and their potential application in cancer treatment.
    Liang Y; Li Q; Liu Y; Guo Y; Li Q
    Discov Oncol; 2023 May; 14(1):57. PubMed ID: 37148441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression.
    Souza VGP; Forder A; Pewarchuk ME; Telkar N; de Araujo RP; Stewart GL; Vieira J; Reis PP; Lam WL
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of the intratumoral microbiome in various tumors.
    Xue C; Chu Q; Zheng Q; Yuan X; Su Y; Bao Z; Lu J; Li L
    Cell Rep Med; 2023 Jan; 4(1):100884. PubMed ID: 36652905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome(s) and cancer: know thy neighbor(s).
    González-Sánchez P; DeNicola GM
    J Pathol; 2021 Jul; 254(4):332-343. PubMed ID: 33723873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.
    Yang L; Li A; Wang Y; Zhang Y
    Signal Transduct Target Ther; 2023 Jan; 8(1):35. PubMed ID: 36646684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral microbiota: new frontiers in tumor immunity.
    Zhang Z; Liao Y; Tang D
    Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the intratumoral microbiome in tumor progression and therapeutics implications.
    Meng YF; Fan ZY; Zhou B; Zhan HX
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189014. PubMed ID: 37918451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression With Focus on Breast Cancer Therapeutic Outcomes.
    Chang CM; Pekkle Lam HY
    Anticancer Res; 2024 Jun; 44(6):2271-2285. PubMed ID: 38821615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral bacteria are an important "accomplice" in tumor development and metastasis.
    Wang G; He X; Wang Q
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188846. PubMed ID: 36496095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and its therapeutic implications in tumor microenvironment interactions.
    Feng P; Xue X; Bukhari I; Qiu C; Li Y; Zheng P; Mi Y
    Front Microbiol; 2024; 15():1287077. PubMed ID: 38322318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-oncology-microbiome axis of gastrointestinal malignancy.
    Lin Q; Guan SW; Yu HB
    World J Gastrointest Oncol; 2023 May; 15(5):757-775. PubMed ID: 37275452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
    Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
    Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.